Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patients

Digestion

Volumn 91, Issue 1, 2015, Pages 57-63

  Nosho, Katsuhiko ^a   Igarashi, Hisayoshi ^a   Ito, Miki ^a   Mitsuhashi, Kei ^a   Kurihara, Hiroyoshi ^a   Kanno, Shinichi ^a   Yoshii, Shinji ^b,f   Mikami, Masashi ^a   Takahashi, Hiroaki ^b   Kusumi, Takaya ^e   Hosokawa, Masao ^e   Sukawa, Yasutaka ^a   Adachi, Yasushi ^a   Hasegawa, Tadashi ^b   Okita, Kenji ^c   Hirata, Koichi ^c   Maruyama, Reo ^d   Suzuki, Hiromu ^d   Imai, Kohzoh ^g   Yamamoto, Hiroyuki ^h   Shinomura, Yasuhisa ^a   more..

^a University School of Medicine   (Japan)

^b Surgical Oncology and Science ^*  (Japan)

^c Surgical Oncology and Science   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Keiyukai Sapporo Hospital   (Japan)

^f Sapporo Medical Center   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Colonoscopy; Colorectal cancer; Hyperplastic polyp

Indexed keywords

B RAF KINASE; CACNA1G PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICRORNA 31; PROTEIN; PROTEIN MLH1; RASSF2 PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; AGED; ASCENDING COLON; CECUM; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; CONFERENCE PAPER; CPG ISLAND; CYTOLOGICAL DYSPLASIA; DESCENDING COLON; DNA METHYLATION; DYSPLASIA; FEMALE; GENE MUTATION; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM; RECTUM ADENOMA; ADENOMA; ASIAN CONTINENTAL ANCESTRY GROUP; CLASSIFICATION; COLON; COLON POLYP; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; JAPAN; MUTATION; PATHOLOGY; PHENOTYPE; VERY ELDERLY;

ADENOMA; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; JAPAN; MALE; MICROSATELLITE INSTABILITY; MUTATION; PHENOTYPE;

EID: 84922309881     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000368820     Document Type: Conference Paper

References (35)

1. Nosho K, Igarashi H, Nojima M, Ito M, Maruyama R, Yoshii S, Naito T, Sukawa Y, Mikami M, Sumioka W, Yamamoto E, Kurokawa S, Adachi Y, Takahashi H, Okuda H, Kusumi T, Hosokawa M, Fujita M, Hasegawa T, Okita K, Hirata K, Suzuki H, Yamamoto H, Shinomura Y: Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway. Carcinogenesis 2014; 35: 776-783.
2. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS: CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90-96.
3. Okada Y, Miyamoto H, Goji T, Takayama T: Biomarkers for predicting the efficacy of antiepidermal growth factor receptor antibody in the treatment of colorectal cancer. Digestion 2014; 89: 18-23.
4. Bentz S, Cee A, Endlicher E, Wojtal KA, Naami A, Pesch T, Lang S, Schubert P, Fried M, Weber A, Coy JF, Goelder S, Knuchel R, Hausmann M, Rogler G: Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Digestion 2013; 88: 182-192.
5. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ: Factors associated with the risk of adenoma recurrence in distal and proximal colon. Digestion 2013; 87: 141-146.
6. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S: Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012; 367: 1596-1606.
7. Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S: A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009; 137: 1609-1620.e3.
8. Edelstein DL, Axilbund JE, Hylind LM, Romans K, Griffin CA, Cruz-Correa M, Giardiello FM: Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2013; 62: 404-408.
9. Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Woodall S, Arnold J, Walker NI, Jass JR, Parry S, Young JP: Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012; 36: 876-882.
10. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J: Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315-1330.
11. Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, Grady WM, Zhu LC, Upton MP, Makar KW: Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res 2013; 73: 2863-2872.
12. Fujita K, Yamamoto H, Matsumoto T, Hirahashi M, Gushima M, Kishimoto J, Nishiyama K, Taguchi T, Yao T, Oda Y: Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol 2011; 35: 295-304.
13. Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA: Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol 2012; 138: 356-366.
14. Mohammadi M, Kristensen MH, Nielsen HJ, Bonde JH, Holck S: Qualities of sessile serrated adenoma/polyp/lesion and its borderline variant in the context of synchronous colorectal carcinoma. J Clin Pathol 2012; 65: 924-927.
15. Kaji E, Uraoka T, Kato J, Hiraoka S, Suzuki H, Akita M, Saito S, Tanaka T, Ohara N, Yamamoto K: Externalization of saw-tooth architecture in small serrated polyps implies the presence of methylation of IGFBP7. Dig Dis Sci 2012; 57: 1261-1270.
16. Rosty C, Hewett DG, Brown IS, Leggett BA, Whitehall VL: Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol 2013; 48: 287-302.
17. Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y: MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. Int J Cancer 2014; 135: 2507-2515.
18. Naito T, Nosho K, Ito M, Igarashi H, Mitsuhashi K, Yoshii S, Aoki H, Nomura M, Sukawa Y, Yamamoto E, Adachi Y, Takahashi H, Hosokawa M, Fujita M, Takenouchi T, Maruyama R, Suzuki H, Baba Y, Imai K, Yamamoto H, Ogino S, Shinomura Y: IGF2 DMR hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroenterol 2014; 20: 10050-10061.
19. Dhir M, Yachida S, van Neste L, Glockner SC, Jeschke J, Pappou EP, Montgomery EA, Herman JG, Baylin SB, Iacobuzio-Donahue C, Ahuja N: Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. Int J Cancer 2011; 129: 1889-1898.
20. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686.
21. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793.
22. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S: Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012; 61: 847-854.
23. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S: Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 2008; 3:e3698.
24. Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, Muzny D, Sander C, Hamilton SR, Gibbs RA, Wheeler D: MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J Pathol 2013; 229: 99-110.
25. Leggett B, Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-2100.
26. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V: The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62: 367-386.
27. Lochhead P, Kuchiba A, Imamura Y, Liao X, Yamauchi M, Nishihara R, Qian ZR, Morikawa T, Shen J, Meyerhardt JA, Fuchs CS, Ogino S: Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst 2013; 105: 1151-1156.
28. Perea J, Rueda D, Canal A, Rodriguez Y, Alvaro E, Osorio I, Alegre C, Rivera B, Martinez J, Benitez J, Urioste M: Age at onset should be a major criterion for subclassification of colorectal cancer. J Mol Diagn 2014; 16: 116-126.
29. Chen D, Huang JF, Liu K, Zhang LQ, Yang Z, Chuai ZR, Wang YX, Shi DC, Huang Q, Fu WL: BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-Analysis. PLoS One 2014; 9:e90607.
30. Nosho K, Yamamoto H, Takahashi T, Mikami M, Taniguchi H, Miyamoto N, Adachi Y, Arimura Y, Itoh F, Imai K, Shinomura Y: Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers. Carcinogenesis 2007; 28: 1364-1370.
31. Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, Itoh F, Imai K, Sugai T, Shen L, Issa JP, Shinomura Y, Tokino T, Toyota M: IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 2010; 31: 342-349.
32. Yamamoto E, Suzuki H, Yamano HO, Maruyama R, Nojima M, Kamimae S, Sawada T, Ashida M, Yoshikawa K, Kimura T, Takagi R, Harada T, Suzuki R, Sato A, Kai M, Sasaki Y, Tokino T, Sugai T, Imai K, Shinomura Y, Toyota M: Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Am J Pathol 2012; 181: 1847-1861.
33. Ricciardiello L, Goel A, Mantovani V, Fiorini T, Fossi S, Chang DK, Lunedei V, Pozzato P, Zagari RM, De Luca L, Fuccio L, Martinelli GN, Roda E, Boland CR, Bazzoli F: Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res 2003; 63: 787-792.
34. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN: Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-3460.
35. Sheridan TB, Fenton H, Lewin MR, Burkart AL, Iacobuzio-Donahue CA, Frankel WL, Montgomery E: Sessile serrated adenomas with low-And high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions 'caught in the act'. Am J Clin Pathol 2006; 126: 564-571.